Promethazine and Repatha drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Promethazine (promethazine hydrochloride) and Repatha (evolocumab). Common drug interactions include knee arthroplasty among females and muscle spasms among males.
The phase IV clinical study analyzes what interactions people have when they take Promethazine and Repatha. It is created by eHealthMe based on reports of 60 people who take the same drugs from the FDA, and is updated regularly.
What is Promethazine?
Promethazine has active ingredients of promethazine hydrochloride. It is often used in nausea. eHealthMe is studying from 32,300 Promethazine users. Check the latest studies of Promethazine.
What is Repatha?
Repatha has active ingredients of evolocumab. It is often used in high blood cholesterol. eHealthMe is studying from 156,258 Repatha users. Check the latest studies of Repatha.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
60 people who take Promethazine and Repatha together, and have interactions are studied.

What are the common drug interactions of Promethazine and Repatha, by gender? *:
female:
- Knee arthroplasty
- Muscle spasms (muscle contraction)
- Nasopharyngitis (inflammation of the nasopharynx)
- Pain in extremity
- Procedural pain
- Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
- Tendonitis (a condition that causes pain and swelling of tendons)
- Adrenal mass
- Angioplasty
- Arterial insufficiency (lack of enough blood flow through the arteries)
male:
- Muscle spasms (muscle contraction)
- Pain
- Blood phosphorus increased
- Blood urine present
- Calculus urethral (stone in urethra)
- Chest pain
- Chronic kidney disease
- Dysstasia (difficulty in standing)
- Emotional distress
- Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
What are the common drug interactions of Promethazine and Repatha, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Influenza like illness
- Muscle spasms (muscle contraction)
- Muscle tightness
- Pain
50-59:
- Asthenia (weakness)
- Blood phosphorus increased
- Blood urine present
- Calculus urethral (stone in urethra)
- Dysstasia (difficulty in standing)
- Emotional distress
- Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
- Gait disturbance
- General physical condition
- Glycosuria (excretion of glucose into the urine)
60+:
- Arthralgia (joint pain)
- Chest pain
- Therapeutic response decreased (less preventive response)
- Wheezing (a high-pitched whistling sound made while you breath)
- Chest discomfort
- Muscle spasms (muscle contraction)
- Epistaxis (bleed from the nose)
- Dyspnoea exertional (breathlessness or shortness of breath)
- Fatigue (feeling of tiredness)
- Hyperhidrosis (abnormally increased sweating)
What are the existing conditions these people have? *
- Immunodeficiency Common Variable: 10 people, 16.67%
- Hyperlipidaemia (presence of excess lipids in the blood): 8 people, 13.33%
- High Blood Pressure: 7 people, 11.67%
- Asthma: 5 people, 8.33%
- Psoriasis (immune-mediated disease that affects the skin): 5 people, 8.33%
- Headache (pain in head): 5 people, 8.33%
- Hiv Infection: 5 people, 8.33%
- Weight Decreased: 4 people, 6.67%
- Autoimmune Disorder (a condition in which the immune system attacks the body's normal substances and tissue): 4 people, 6.67%
- Blood Pressure Abnormal: 4 people, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take Promethazine and Repatha?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Promethazine (32,300 reports)
- Repatha (156,258 reports)
Browse all drug interactions of Promethazine and Repatha:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Promethazine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Repatha:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Promethazine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Repatha and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
- Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on promethazine hydrochloride and evolocumab (the active ingredients of Promethazine and Repatha, respectively), and Promethazine and Repatha (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Citalopram Hydrobromide cause Otitis Externa? - 11 seconds ago
- Could Hivid cause Joint Pain? - 11 seconds ago
- Bactrim and Hypophosphataemia for Women aged 40-49 - 19 seconds ago
- Could Stalevo 100 cause Acute Upper Airway Obstruction? - 19 seconds ago
- Could Neulasta cause Rash Erythematous Aggravated? - 33 seconds ago
- Could Benadryl cause Hypokalemia? - 38 seconds ago
- Pentoxifylline and Aspirin drug interactions for men aged 60+ - 41 seconds ago
- Could Trelegy Ellipta cause Coronary Heart Disease? - 42 seconds ago
- Could Potassium Iodide cause Basal Cell Carcinoma? - 44 seconds ago
- Could Heparin Lock Flush cause Constipation? - 44 seconds ago